Surmodics, Inc. provided earnings guidance for the year 2024. For the year, the company expects total revenue to range from $116 million to $121 million, representing a decrease of (13)% to (9)% compared to fiscal 2023. The company expects fiscal 2024 GAAP diluted loss per share to range from $1.55 to $1.20.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
31.94 USD | +1.09% | -8.16% | -12.71% |
05-02 | Barrington Ups Price Target on SurModics to $71 From $70, Maintains Outperform Rating | MT |
05-01 | Top Midday Gainers | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.71% | 450M | |
-4.78% | 183B | |
-0.59% | 108B | |
-3.75% | 67.51B | |
+4.05% | 50.67B | |
+9.47% | 44.7B | |
+2.41% | 40.95B | |
+3.48% | 26.8B | |
+3.39% | 26.71B | |
+12.66% | 24.62B |
- Stock Market
- Equities
- SRDX Stock
- News Surmodics, Inc.
- Surmodics, Inc. Provides Earnings Guidance for the Year 2024